GlucoTrack, Inc.

Contributing Author

Recent Articles by GlucoTrack, Inc.

Mar-30	Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights GCTK -23.57% GCTK -14.11% GlobeNewswire
Mar-27	Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones GCTK -9.16% GlobeNewswire
Mar-10	Glucotrack to Present at LSI USA '26 Medtech Innovation Summit GCTK GlobeNewswire
Jan-29	Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform GCTK -33.43% GlobeNewswire
Dec-30	Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor GCTK -10.85% GlobeNewswire
Nov-13	Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights GCTK -8.64% GCTK GlobeNewswire
Nov-03	Glucotrack, Inc. Encourages Shareholders to Vote GCTK -5.88% GCTK GlobeNewswire
Oct-29	Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team GCTK -11.64% GlobeNewswire
Oct-28	Glucotrack, Inc. Reminds Shareholders to Vote GCTK +9.94% GlobeNewswire
Sep-11	Glucotrack to Participate in the Q3 Virtual Investor Summit GCTK +5.18% GlobeNewswire
Aug-14	Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights GCTK GlobeNewswire
Aug-06	Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology GCTK GlobeNewswire
Jul-31	Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting GCTK GlobeNewswire
Jul-08	Glucotrack Announces Repurchase of Series A Warrants GCTK GlobeNewswire
Jun-25	Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions GCTK +26.25% GlobeNewswire
Jun-12	Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements GCTK -33.81% GlobeNewswire
Jun-04	Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions GCTK GlobeNewswire
May-28	Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD GCTK GlobeNewswire
May-20	Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development GCTK GlobeNewswire
May-14	Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights GCTK GlobeNewswire
May-13	Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor GCTK GlobeNewswire

GlucoTrack, Inc.

Recent Articles by GlucoTrack, Inc.

Upgrade your Finviz experience